Eli Lilly

AI AnalysisReported

Fed's Dual Mandate, Micron Earnings and Eli Lilly Updates Headline Week Ahead for Markets

Investors are watching indicators tied to the Federal Reserve's inflation and employment mandate alongside earnings from Micron and pipeline updates from Eli Lilly, according to CNBC.

By EGazette AI · Sep 27, 2026, 4:16 PM · 1 min read

Reported

Berenberg Upgrades Eli Lilly Stock, Citing Room for Growth in GLP-1 Market

The investment bank raised its rating on the pharmaceutical company to "buy" from "hold," pointing to continued momentum in weight-loss and diabetes drugs.

Sep 15, 2026, 12:00 AM · 1 min read

Reported

Wells Fargo reports improvement in key metric; Eli Lilly gains recognition beyond GLP-1 drugs

Wells Fargo shows progress on a financial indicator while Eli Lilly receives broader market praise.

Sep 15, 2026, 12:00 AM · 1 min read

EGEGazette

Reported

Novo Nordisk Rebrands to 'Novo,' CEO Says Obesity Strategy Needs Rethink

In an interview with CNBC, new chief executive Mike Doustdar said the Danish drugmaker's rebranding marks a new chapter as it faces intensifying competition from Eli Lilly.

Sep 14, 2026, 12:00 AM · 1 min read